Lisuride and LSD: dopaminergic and serotonergic interactions in the "serotonin syndrome"
- PMID: 117494
- DOI: 10.1007/BF00492209
Lisuride and LSD: dopaminergic and serotonergic interactions in the "serotonin syndrome"
Similar articles
-
Locomotor effects of lisuride: a consequence of dopaminergic and serotonergic actions.Psychopharmacology (Berl). 1985;85(4):464-8. doi: 10.1007/BF00429666. Psychopharmacology (Berl). 1985. PMID: 2991961
-
Lysergic acid diethylamide (LSD) and lisuride: differentiation of their neuropharmacological actions.Science. 1982 Apr 30;216(4545):535-7. doi: 10.1126/science.7071600. Science. 1982. PMID: 7071600
-
Comparative effects of LSD and lisuride: clues to specific hallucinogenic drug actions.Pharmacol Biochem Behav. 1986 Feb;24(2):365-79. doi: 10.1016/0091-3057(86)90367-9. Pharmacol Biochem Behav. 1986. PMID: 3952127
-
LSD, 5-HT (serotonin), and the evolution of a behavioral assay.Neurosci Biobehav Rev. 2004 Jan;27(8):693-701. doi: 10.1016/j.neubiorev.2003.11.012. Neurosci Biobehav Rev. 2004. PMID: 15019419 Review.
-
[Agents to improve cerebrovascular circulation and cerebral metabolism--lisuride].Nihon Rinsho. 1985 Feb;43(2):397-401. Nihon Rinsho. 1985. PMID: 3889414 Review. Japanese. No abstract available.
Cited by
-
The G protein biased serotonin 5-HT2A receptor agonist lisuride exerts anti-depressant drug-like activities in mice.Front Mol Biosci. 2023 Oct 10;10:1233743. doi: 10.3389/fmolb.2023.1233743. eCollection 2023. Front Mol Biosci. 2023. PMID: 37900918 Free PMC article.
-
Growth hormone and prolactin stimulation by Madopar in Parkinson's disease.J Neurol Neurosurg Psychiatry. 1981 Dec;44(12):1116-23. doi: 10.1136/jnnp.44.12.1116. J Neurol Neurosurg Psychiatry. 1981. PMID: 7334406 Free PMC article.
-
Binding of antiparkinsonian ergot derivatives to the dopamine receptor.Psychopharmacology (Berl). 1981;75(2):119-23. doi: 10.1007/BF00432172. Psychopharmacology (Berl). 1981. PMID: 6798600
-
The crosstalk between 5-HT2AR and mGluR2 in schizophrenia.Neuropharmacology. 2023 Jun 1;230:109489. doi: 10.1016/j.neuropharm.2023.109489. Epub 2023 Mar 6. Neuropharmacology. 2023. PMID: 36889432 Free PMC article. Review.
-
Molecular Pathways Potentially Involved in Hallucinatory Experiences During Sleep Paralysis: The Emerging Role of β-Arrestin-2.Int J Mol Sci. 2025 Jul 26;26(15):7233. doi: 10.3390/ijms26157233. Int J Mol Sci. 2025. PMID: 40806366 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources